POST Online Media Lite Edition



 

Cellectar Biosciences appoints Igor Grachev as chief medical officer

Christian Fernsby |
Florham Park, N.J., USA - Cellectar Biosciences, a clinical-stage biopharmaceutical company, announced it has appointed Igor Grachev as chief medical officer.


Dr. Grachev brings nearly 20 years of industry experience to Cellectar having led clinical development programs at both multinational pharmaceutical and biotech organizations.

Dr. Grachev served as Global Development Leader and Head of Innovative Clinical Trials Initiative for TEVA Branded Specialty Pharmaceuticals.

He also had clinical development and medical affairs leadership roles for GE Healthcare, Novartis, GSK, Merck, Schering Plough, Sanofi-Aventis, and BioClinica.

LATEST 5 MOVES FROM New Jersey